Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.

NCT06375499 is registered in ClinicalTrials.gov with Laboratoires Thea as lead sponsor.

NCT NCT06375499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06375499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of the Performance and Safety of T2769 Versus Hylo-Forte® in the Treatment of Moderate to Severe Dry Eye Syndrome.
Lead sponsor
Laboratoires Thea
Phase
Not applicable
Overall status
Completed
Start date
September 17, 2024
Completion date
January 6, 2025
Enrollment
74 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

dry eye syndrome